Molina Healthcare (NYSE:MOH) Price Target Lowered to $225.00 at Truist Financial

Molina Healthcare (NYSE:MOH) had its price objective reduced by analysts at Truist Financial from $250.00 to $225.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 15.38% from the company’s current price.

Several other equities analysts also recently weighed in on MOH. Mizuho set a $215.00 target price on shares of Molina Healthcare in a report on Monday, June 8th. Royal Bank Of Canada decreased their price target on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating on the stock in a research note on Friday. Weiss Ratings raised shares of Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 25th. UBS Group increased their target price on Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $129.00 price target on shares of Molina Healthcare in a research report on Friday, April 24th. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus target price of $203.38.

Molina Healthcare Stock Performance

MOH traded down $5.28 during trading on Friday, reaching $195.01. The company’s stock had a trading volume of 581,867 shares, compared to its average volume of 1,541,820. The company has a market capitalization of $10.16 billion, a price-to-earnings ratio of -1,085.81 and a beta of 0.74. The company’s fifty day moving average price is $205.93 and its 200-day moving average price is $176.87. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $244.89. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.74%. The business’s revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.48 EPS. On average, equities analysts forecast that Molina Healthcare will post 5.23 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its stake in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after purchasing an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after acquiring an additional 201,772 shares during the period. Invesco Ltd. increased its position in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock valued at $293,453,000 after purchasing an additional 329,679 shares during the period. Victory Capital Management Inc. raised its stake in shares of Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after buying an additional 447,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock worth $185,929,000 after acquiring an additional 267,121 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina beat Q2 earnings expectations, reporting $1.51 per share versus the $1.39 consensus, and revenue of $10.87 billion slightly topped estimates. The company also raised its 2026 earnings outlook, which shows management still sees profitability holding up better than expected. Article: MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised
• Neutral Sentiment: Analysts continue to view Molina as a hold, with consensus ratings staying cautious rather than turning more bullish. Article: Molina Healthcare, Inc (NYSE:MOH) Receives Consensus Recommendation of “Hold” from Analysts
• Neutral Sentiment: Royal Bank of Canada cut its price target on MOH from $248 to $218 and kept a “sector perform” rating, signaling less upside conviction after the results. Article: Molina Healthcare price target lowered by RBC
• Negative Sentiment: Investors are worried about lower premium revenue, declining membership, and a higher medical care ratio, which pressured sentiment despite the earnings beat. Article: Molina Healthcare Posts Lower Profit, Revenue as Membership Declines
• Negative Sentiment: Coverage also highlighted concerns that Molina may reduce its Obamacare footprint, reinforcing fears that growth could slow if enrollment and product mix remain weak. Article: Molina plummets as it expects to halve its Obamacare presence

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.